| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 10/02/1997 | CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 10/01/1997 | EP0797995A2 Use of a 5-HT2 receptor antagonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis |
| 10/01/1997 | EP0797993A1 Compostions comprising l-carnitine or derivatives thereof and antioxidants |
| 10/01/1997 | EP0797576A1 Alkyl substituted piperadinyl and piperazinyl anti-aids compounds |
| 10/01/1997 | EP0797452A1 Modulating the immune response |
| 10/01/1997 | EP0797437A1 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a) |
| 10/01/1997 | EP0797427A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| 10/01/1997 | CN1161058A Intracellular isoform of the interleukin-1 receptor antagonist |
| 10/01/1997 | CN1161041A Heterocycle-condensed morphinoid derivatives |
| 10/01/1997 | CN1161040A Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 10/01/1997 | CN1161000A Topical ophthalmic formulations containing Doxepin derivatives for treating allergic eye diseases |
| 09/30/1997 | US5672610 Therapy for immunosuppression |
| 09/30/1997 | US5672605 Macrolide immunomodulators |
| 09/30/1997 | US5672602 Substituted piperazine derivatives |
| 09/30/1997 | US5672590 Consists of d-ribose, 2-deoxy-d-ribose, alpha-alanine, nicotinic acid and l-ascorbic acid; stimulating the production of cytokines |
| 09/30/1997 | US5672486 Protein polyligands joined to a stable protein core |
| 09/30/1997 | US5672473 Methods of identifying compounds useful for treating autoimmune diseases |
| 09/25/1997 | WO1997035193A1 Cryptic peptides and method for their identification |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997035006A1 Human cell death-associated protein |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034895A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use |
| 09/25/1997 | WO1997034893A1 Pharmaceutically useful compounds |
| 09/25/1997 | WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 09/25/1997 | WO1997034874A1 1,3,5-trisubstituted indazole derivatives with an anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating action |
| 09/25/1997 | WO1997034636A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/25/1997 | WO1997034633A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/25/1997 | WO1997034622A1 Oral cyclosporin formulations |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997034617A1 Hla binding peptides and their uses |
| 09/25/1997 | WO1997034600A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 09/25/1997 | WO1997034472A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | WO1997026867A3 Solid instant-release forms of administration and process for producing the same |
| 09/25/1997 | WO1997019113A3 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 09/25/1997 | WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/25/1997 | DE19610955A1 Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid Combination preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl) - anilide and N- (4-trifluoromethylphenyl) -2-cyano-3- hydroxycrotonamide |
| 09/25/1997 | DE19610882A1 Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 1,3,5-tri-substituted indazole derivatives having anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect, processes for their preparation and their use as medicaments |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249739A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use |
| 09/25/1997 | CA2249412A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | CA2248868A1 Apoptosis inducing molecule ii |
| 09/25/1997 | CA2248659A1 Hla binding peptides and their uses |
| 09/25/1997 | CA2248614A1 Human cell death-associated protein |
| 09/25/1997 | CA2247814A1 Pharmaceutically useful compounds |
| 09/24/1997 | EP0796330A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 09/24/1997 | EP0796320A1 Human dna ligase iii |
| 09/24/1997 | EP0796280A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/24/1997 | EP0796276A1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 09/24/1997 | EP0796260A1 Rapamycin 42-oximes and hydroxylamines |
| 09/24/1997 | EP0796096A1 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 09/24/1997 | EP0796093A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 09/24/1997 | EP0796092A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds |
| 09/24/1997 | EP0796091A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds |
| 09/24/1997 | EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| 09/24/1997 | EP0617705B1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 09/24/1997 | EP0491708B1 Isolating aminoarginine and use to block nitric oxide formation in body |
| 09/24/1997 | CN1160402A Purine and guanine compounds as inhibitors of PNP |
| 09/24/1997 | CN1160399A Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists |
| 09/24/1997 | CN1160398A Compositions and methods for treating mast-cell inflammatory condition |
| 09/24/1997 | CN1160397A Azole deriv. |
| 09/24/1997 | CN1160356A Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 09/24/1997 | CN1160352A Diazepino-indoles as phosphodiesterase IV inhibitors |
| 09/24/1997 | CN1160350A HIV protease inhibitor combination |
| 09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1035944C Method for preparing 3-aminopiperidine derivs. and related nitrogen-contg. heterocycles |
| 09/24/1997 | CN1035925C Method for preparation of cytotropic non-homogeneous molecular lipid |
| 09/23/1997 | US5670675 Retroviral protease inhibiting compounds |
| 09/23/1997 | US5670626 Allergen-specific human IgA monoclonal antibodies for mucosal administration |
| 09/23/1997 | US5670540 Triglycerides of fatty acids |
| 09/23/1997 | US5670537 Method for effecting tumor regression with a low dose, short infusion taxol regimen |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/23/1997 | US5670520 Method for inhibiting virus replication in mammalian cells using carbostyil derivatives |
| 09/23/1997 | US5670505 Tachykikin antagonist for respiratory diseases, ophthalmic diseases and antiinflammatory agents |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670494 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 09/23/1997 | US5670153 Immunoreactive polypeptide compositions |
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670148 Combined cellular and immunosuppressive therapies |
| 09/20/1997 | CA2200385A1 1,3,5-trisubstituted indazole derivatives, processes for preparing, and for pharmacological treatment therewith |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997033910A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 09/18/1997 | WO1997033881A1 Bicyclic-aromatic compounds |
| 09/18/1997 | WO1997033616A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | WO1997033615A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 09/18/1997 | WO1997033614A1 Use of coxiella bacteria to treat autoimmune disease |
| 09/18/1997 | WO1997033552A1 Water soluble paclitaxel prodrugs |
| 09/18/1997 | CA2248537A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | CA2246427A1 Methods for treatment of allergic diseases with ige |
| 09/17/1997 | EP0795556A1 4-Substituted pyrrolopyrimidine compounds as tyrosin kinase inhibitors |
| 09/17/1997 | EP0795334A2 Prodrugs for the treatment tumors and inflammatory diseases |
| 09/17/1997 | EP0795017A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 09/17/1997 | EP0794966A1 Humanized antibodies to cd38 |
| 09/17/1997 | EP0794955A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0794793A1 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |